News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Inrig Jula
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2023 |
4
| Inrig Jula (Chief Medical Officer) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 2,051 shares
@ $20.75, valued at
$42.6k
Sold 442 shares
@ $20.75, valued at
$9.2k
|
|
| 02/02/2022 |
4
| Inrig Jula (Chief Medical Officer) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $0 |
|
| 01/04/2022 |
4
| Inrig Jula (Chief Medical Officer) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 80,000 options to buy
@ $30.6, valued at
$2.4M
|
|
| 01/04/2022 |
3
| Inrig Jula (Chief Medical Officer) has filed a Form 3 on Travere Therapeutics, Inc. |
|
|